Results 291 to 300 of about 640,739 (357)
Primary vitreoretinal lymphoma is an incredibly rare non‐Hodgkin lymphoma with no clear international consensus guidelines for diagnosis and management. This study highlights the significant real‐world heterogeneity in diagnostic and management approaches of this rare condition. In particular, the incorporation of systemic therapy to initial management
Catherine Tang+17 more
wiley +1 more source
ABSTRACT Background High myopia (HM) is a major risk factor for glaucoma. However, glaucomatous optic neuropathy is often undiagnosed owing to atypical structural alterations with axial elongation. Moreover, an algorithm to detect glaucoma in highly myopic eyes has not yet been reported.
Xiaohong Chen+14 more
wiley +1 more source
Outer retina micro-inflammation is driven by T cell responses prior to retinal degeneration in early age-related macular degeneration. [PDF]
Stürzbecher L+10 more
europepmc +1 more source
ABSTRACT Background In the last two decades, over 250 000 refugees and asylum seekers have arrived in Australia, many of whom experience significant health problems. Information about their eye health is scarce, particularly for those detained offshore. This is the first study to explore the eye health and services available to this population, helping
Marcel M. Nejatian+3 more
wiley +1 more source
Recycling the recyclers: lysophagy emerges as a new pharmacological target for retinal degeneration. [PDF]
Jiménez-Loygorri JI, Boya P.
europepmc +1 more source
Cataract Surgery in the Small Adult Eye: A Review
ABSTRACT Modern cataract surgery continues to advance, yet intraocular lens (IOL) based surgery in the small adult eye remains challenging. Thorough preoperative assessment and surgical preparation optimise postoperative outcomes in these cases. Advances in IOL power calculation, including artificial intelligence‐driven formulas, improve accuracy ...
Jonathan E. Moore+2 more
wiley +1 more source
Safety of an Intravitreal Bevacizumab Biosimilar (MVASI)
ABSTRACT Background Intravitreal bevacizumab has been used off‐label to treat multiple ocular conditions for almost two decades. Reference bevacizumab, Avastin, was discontinued in Australia in 2021. A bevacizumab biosimilar, MVASI, was approved by the Therapeutic Goods Administration for the treatment of metastatic cancer in 2020.
Hanru Wang+8 more
wiley +1 more source
Preservation of vision by transpalpebral electrical stimulation in mice with inherited retinal degeneration. [PDF]
Gunes K+8 more
europepmc +1 more source
Presbyopia Correction in Lens Replacement Surgery: A Review
ABSTRACT Presbyopia affects approximately 1.8 billion individuals globally, posing significant challenges as life expectancy and near‐vision demands, particularly with mobile phone use, grow. Addressing presbyopia during lens replacement surgery has become a key focus for cataract surgeons, aiming to reduce dependence on corrective eyewear. This review
Benjamin Stern, Damien Gatinel
wiley +1 more source
Avidity sequencing of whole genomes from retinal degeneration pedigrees identifies causal variants. [PDF]
Biswas P+9 more
europepmc +1 more source